EVALUATES ADMINISTRATION OF OXYTOCIN DRUG IN MATERNITY AND ITS IMPLICATIONS: SHORT ARTICLE REVIEW
Introduction: Oxytocin exerts a variety of actions and involvement in a large number of physiological and pathological processes. Objectives: Study aims to evaluate Oxytocin use in Maternity setting, we examine foremost the availability, and to a lesser extent the administration of Oxytocin. As such, we assess the extent to which international unified guidelines have adhered to obstetric care. Methods: A plan was designed and a systematic search was conducted in PubMed and CINAHL. We screen the search on title and abstract after duplicates were removed (n = 100), 65 articles were examined in full-text and 28 papers met inclusion criteria. As the articles varied in methodology used for analysis of oxytocin levels, a descriptive synthesis was created. Result: The most studied routes, and doses of Oxytocin is a single 10-unit intramuscular (IM) dose or an intravenous (IV) Infusion of 20 to 40 units of Oxytocin in 1,000 ml of saline or lactated Ringer, s solution. Although, this one of the main focuses of midwifery work, it is surprising how little understand about how midwives can help women during these processes and how Oxytocin levels can be maintain. Conclusion: Currently, no standard recommendations regard the dose, rate, and duration of intravenous Oxytocin administration, nor is there a consensus on whether an intravenous bolus of Oxytocin should administer before starting an Oxytocin infusion Studies should perform to evaluate whether, patients at high risk for hemorrhage require a different Oxytocin infusion strategy than low-risk patients.
Oxytocin-Maternity-Administration, Active Management Third Stage of Labor.